期刊文献+

右美托咪定复合舒芬太尼在下肢骨折患者术后静脉自控镇痛中的应用 被引量:61

Effect of sufentanil combined with dexmedetomidine on postoperative patient-controlled intravenous analgesia in patients undergoing lower limb fracture surgery
在线阅读 下载PDF
导出
摘要 目的:评价右美托咪定复合舒芬太尼在下肢骨折患者术后静脉自控镇痛(PCIA)中的应用效果。方法150例择期全麻下行下肢骨折切开复位内固定患者,美国麻醉师协会(ASA)分级为Ⅰ~Ⅱ级,随机均等分为5组:不同剂量舒芬太尼组(S1、S2组),舒芬太尼复合不同剂量右美托咪定组(M1、M2、M3组)。于手术结束即刻行 PCIA,均用生理盐水稀释至100 ml,首次剂量均为舒芬太尼0.1μg/ kg,静脉镇痛泵背景输注速度2 ml/ h,自控给药剂量0.5 ml,锁定时间15 min。分别于术后1(T1)、3(T2)、6(T3)、12(T4)、24(T5)和48 h(T6)各时间点,采用视觉模拟评分法(VAS)评价患者疼痛程度及 Ramsay 镇静评分评价患者镇静程度;记录患者术后48 h 内 PCIA 按压总次数及地佐辛用量;并记录术后48 h内恶心、呕吐、皮肤瘙痒、呼吸抑制和低血压的发生情况。结果与 S1、M1组比较,S2、M2、M3组 T1~ T6 VAS 评分降低(P 〈0.05),M3组 T1~ T6 Ramsay 评分升高(P 〈0.05),S2、M2、M3组 PCIA 按压总次数及地佐辛消耗量均减少( P 〈0.05)。M2组未出现并发症,S2组较 S1、M1、M2、M3组恶心呕吐、皮肤瘙痒、呼吸抑制发生例数增加(P 〈0.05);M2、M3组较 S1组恶心呕吐发生例数减少(P 〈0.05);M3组较 M2组呼吸抑制发生例数增加(P 〈0.05);M3组较 S1、S2、M1、M2组低血压发生例数增加(P 〈0.05)。结论2μg/ kg 舒芬太尼联合2μg/ kg 右美托咪定镇痛效果满意,副反应少,是骨科患者术后镇痛的较佳配方。 Objective To investigate the effect of combining dexmedetomidine(Dex)and sufentanil on postopera-tive patient-controlled intravenous analgesia(PCIA)in patients of lower limb fracture. Methods One hundred and fifty patients,ASAⅠ ~ Ⅱ,undergoing lower limb fracture surgery,were randomly divided into five groups:different doses of sufentanil groups(S1,S2 group)and sufentanil combining with different doses of dexmedetomidine groups (M1,M2,M3 group). At the end of the surgery,patients immediately received postoperative PCIA. All drugs were diluted with saline to 100 ml. PCIA was set as follows:background infusion 2 ml/ h;bolus dose 0. 1 μg / kg;PCA dose 0. 5 ml;loekout interva 15 min. The scores of VAS and RSS were recorded at 1,3,6,12,24 and 48 hours after PCIA. The press number,dezocine consuming and the incidence rate of the nausea,vomiting,pruritus,respiratory depression and hypotension were recorded for 48 hours. Results Compared with group S1,M1,the VAS score was significantly decreased at T1 ~ T6 in S2,M2,M3(P 〈 0. 05). The RSS score was significantly increased at T1~ T6 in M3(P 〈 0. 05). The press number,and dezocine consuming was significantly decreased at T1 ~ T6 in S2, M2,M3(P 〈 0. 05). There were no complications in group M2. The occurrence of nausea,vomiting,pruritus,re-spiratory depression was significantly decreased in S1,M1,M2,M3 than S2(P 〈 0. 05). Compared with S1,the oc-currence of nausea and vomiting was significantly decreased in M2,M3(P 〈 0. 05). The occurrence of respiratory depression in M3 Group was significantly higher than M2 group(P 〈 0. 05). The occurrence of hypotension in M3 Group was significantly higher than other groups(P 〈 0. 05). Conclusion Sufentanil 2 μg / kg plus Dex 2 μg / kg has better satisfactory analgesia effect and less side effect. It is a better compound for orthopaedic.
出处 《安徽医科大学学报》 CAS 北大核心 2015年第6期850-854,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金青年科学基金项目(编号:81200171)
关键词 右美托咪定 舒芬太尼 术后镇痛 患者自控静脉镇 效果 dexmedetomidine sufentanil postoperative analgesia patient-controlled intravenous analgesia effect
  • 相关文献

参考文献9

二级参考文献34

  • 1段砺瑕,李晓玲.氟比洛芬酯注射液的药理作用及临床应用[J].中国新药杂志,2004,13(9):851-852. 被引量:602
  • 2冯霞,张春梅,钟艺.舒芬太尼不良反应回顾性调查[J].药物不良反应杂志,2005,7(5):332-335. 被引量:20
  • 3吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 4Kampe S,Randebrock G,Kiencke P,et al.Comparison of continuous epidural infusion of ropivacaine and sufentanil with intravenous patient-controlled analgesia after total hip replacement[J].Anaesthesia,2001,56(12):1189-93.
  • 5Kim M K,Nam S B,Cho M J,et al.Epidural naloxone reduces postoperative nausea and vomiting in patients receiving epidural sufentanil for postoperative analgesia[J].Br J Anaesth,2007,99(2):270-5.
  • 6Fléron M H,Weiskopf R B,Bertrand M,et al.A comparison of intrathecal opioid and intravenous analgesia for the incidence of cardiovascular,respiratory,and renal complications after abdominal aortic surgery[J].Anesth Analg,2003,97(1):2-12.
  • 7Gottschalk A,Smith D S.New concepts in acute pain therapy:preemptive analgesia[J].Am Fam Physician,2001,63(10):1979-84.
  • 8Vuolteenaho K,Moilanen T,Moilanen E.Non-steroidal anti-inflammatory drugs,cyclooxygenase-2 and the bone healing process[J].Clin Pharmacol Toxicol,2008,102(1):10-4.
  • 9Rasmussen G L,Steckner K,Hogue C,et al.Intravenous parecoxib sodium foracute pain after orthopedic knee surgery[J].Am J Orthop,2002,31(6):336-43.
  • 10Nussmeier N A,Whehon A A,Brown M T,et al.Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noneardiac surgery[J].Anesthesiology,2006,104(3):518-26.

共引文献48

同被引文献428

引证文献61

二级引证文献418

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部